BioAmber (FRA:7BA) Capex-to-Revenue : 0.02 (As of Dec. 2017)

BioAmber Capex-to-Revenue Chart

BioAmber Quarterly Data
	Mar13	Jun13	Sep13	Dec13	Mar14	Jun14	Sep14	Dec14	Mar15	Jun15	Sep15	Dec15	Mar16	Jun16	Sep16	Dec16	Mar17	Jun17	Sep17	Dec17
Capex-to-Revenue	Get a 7-Day Free Trial															0.20	0.12	0.04	0.09	0.02

Competitive Comparison of BioAmber's Capex-to-Revenue

For the Chemicals subindustry, BioAmber's Capex-to-Revenue, along with its competitors' market caps and Capex-to-Revenue data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BioAmber's Capex-to-Revenue Distribution in the Chemicals Industry

For the Chemicals industry and Basic Materials sector, BioAmber's Capex-to-Revenue distribution charts can be found below:

* The bar in red indicates where BioAmber's Capex-to-Revenue falls into.

BioAmber Capex-to-Revenue Calculation

BioAmber's Capex-to-Revenue for the fiscal year that ended in Dec. 2017 is calculated as

BioAmber's Capex-to-Revenue for the quarter that ended in Dec. 2017 is calculated as

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BioAmber  (FRA:7BA) Capex-to-Revenue Explanation

Capex-to-Revenue measures a company's investments in physical assets such as property, industrial buildings or equipment to its revenue. The ratio shows how aggressively the company reinvests its revenue back into productive assets. However, a high ratio potentially indicates that the company has invested too much in innovation and infrastructure, taking up funds that could be used to boost productivity and increase revenue. Therefore, a high Capex to Revenue Ratio could be a positive or a negative sign depending on how effectively a company converts those investments into future earnings.

BioAmber Capex-to-Revenue Related Terms

Thank you for viewing the detailed overview of BioAmber's Capex-to-Revenue provided by GuruFocus.com. Please click on the following links to see related term pages.

BioAmber (FRA:7BA) Business Description